Palvella Therapeutics Inc/$PVLA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Palvella Therapeutics Inc
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
Ticker
$PVLA
Sector
Primary listing
Employees
14
Headquarters
Website
PVLA Metrics
BasicAdvanced
$567M
-
-$4.08
-
-
Price and volume
Market cap
$567M
52-week high
$52.87
52-week low
$18.23
Average daily volume
176K
Financial strength
Current ratio
7.669
Quick ratio
7.53
Long term debt to equity
30.37
Total debt to equity
30.37
Interest coverage (TTM)
-5.20%
Profitability
Management effectiveness
Return on assets (TTM)
-37.25%
Return on equity (TTM)
-151.15%
Valuation
Price to book
11.88
Price to tangible book (TTM)
11.88
Price to free cash flow (TTM)
-17.301
Free cash flow yield (TTM)
-5.78%
Free cash flow per share (TTM)
-2.966
Growth
Earnings per share change (TTM)
627.20%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Palvella Therapeutics Inc stock?
Palvella Therapeutics Inc (PVLA) has a market cap of $567M as of August 23, 2025.
What is the P/E ratio for Palvella Therapeutics Inc stock?
The price to earnings (P/E) ratio for Palvella Therapeutics Inc (PVLA) stock is 0 as of August 23, 2025.
Does Palvella Therapeutics Inc stock pay dividends?
No, Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next Palvella Therapeutics Inc dividend payment date?
Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Palvella Therapeutics Inc?
Palvella Therapeutics Inc (PVLA) does not currently have a Beta indicator.